Gilead Sciences, Inc. (GILD) Stock Evaluation

Gilead Sciences, Inc. is a leading American biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines for life-threatening diseases. The company focuses on three major therapeutic areas: virology, oncology, and inflammation. Gilead is renowned for its pioneering work in HIV/AIDS treatment, including the development of the first single-tablet regimen for HIV, as well as its contributions to hepatitis C therapies and COVID-19 treatments. With a global presence spanning over 35 years, Gilead operates in more than 35 countries, leveraging cutting-edge research and development to address unmet medical needs. Founded in 1987 and headquartered in Foster City, California, Gilead continues to transform healthcare through groundbreaking science, partnerships, and a commitment to improving health equity worldwide.

Decision